Clinical trial
Reliability and Validity of the Turkish Version of the PedsQL 3.0 Neuromuscular Module for 2-to 4- Year-old: a Quality-of-life Measure for Patients With Spinal Muscular Atrophy in Turkey
NCT05539456 is registered in ClinicalTrials.gov with Istanbul Medipol University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Reliability and Validity of the Turkish Version of the PedsQL 3.0 Neuromuscular Module for 2-to 4- Year-old: a Quality-of-life Measure for Patients With Spinal Muscular Atrophy in Turkey
- Lead sponsor
- Istanbul Medipol University Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- September 1, 2022
- Completion date
- November 1, 2022
- Enrollment
- 55 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
neuromuscular diseases, pediatric disorder, quality of life, spinal muscular atrophy